Form 4 for EVMN Evommune, Inc.

Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0001742496-25-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2025-11-12	2025-11-07	EVMN	Moss Gregory S.	Chief Business, Legal Off	C - Cnv Deriv	—	+3,175	3,175	New	—
DI	2025-11-12	2025-11-07	EVMN	Moss Gregory S.	Chief Business, Legal Off	C - Cnv Deriv	—	-25.0K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-11-07	C	A	3,175	—	3,175	I By Trust	—	—	(F1) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date. (F2) The securities are held by a family trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.
2	Derivative	Series B Preferred Stock	2025-11-07	C	D	25,000	—	0	I By Trust	— · — to —	3,175 Common Stock	(F1) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date. (F2) The securities are held by a family trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.